Personal injury claims: Why some DCs succeed and some don’t
Master the art of personal injury claims with knowledge, strategies and tactics, tools, staff resources and coaching to build a thriving practice.
What is code 99203?
This article discusses required elements of a code 99203 examination, which leads to reimbursement as well as sound patient care.
Muscle cramps: causes and treatments
Due to the variety of causes and multiple presentations of muscle cramps, effective treatment options and preventative strategies remain elusive.
Social media and patient privacy risks: Post with caution
Entering the world of social media can be a danger zone if you do not understand its risks, and the safeguards necessary to maintain patient privacy.
How big is your digital footprint?
The question isn’t whether you should employ a digital footprint, but deciding how expansive it should be. This depends on time, budget and human support.
The chiropractic e-newsletter: new patient referral and retention machine
Sending a chiropractic e-newsletter is an effective retention, referral and marketing tool. I’ve been sending one to my patients every month for 13 years.
Self-care is not selfish: A message from one chiropractor to many
You can’t help your patients if you don’t take care of yourself I KNOW YOU WERE INSPIRED TO BE A HEALING INFLUENCER. What we do requires a lot of energy. There is nothing mystical about energy. We are born with an innate, although often repressed, ability to use it. Take a moment to think about […]
Best practices for securing your patients’ privacy while using telehealth
While telehealth offers many benefits to both health care providers and patients, ensuring the privacy and security of patient information is critical.
How to navigate social media while maintaining professional boundaries
As a chiropractor in the digital age, it’s critical you maintain professional boundaries in the online world and put social media guidelines in place.
Millions could start using semaglutide medication
Research projects 93 million U.S. adults who are overweight and obese may be suitable for semaglutide, which causes average weight loss of 15%.
